跳至内容
Factliner

AstraZeneca shares drop after $400bn Bristol-Myers deal talks

A potential $400bn merger between AstraZeneca and Bristol-Myers Squibb would create the world's fourth-largest drugmaker but faces investor skepticism.

·1 min read·5 outlets
Photo via FDV / CC BY-SA 4.0

简要版本

AstraZeneca shares fell nearly 9% after reports it was in talks to acquire Bristol-Myers Squibb for $400bn. The combined company would rank among the world's largest pharmaceutical firms.

AstraZeneca shares dropped 8.9% after reports of merger talks with Bristol-Myers Squibb.7 A potential $400bn deal would create one of the world's largest pharmaceutical groups.7,6,5,4,3,2 The combined company would be the world's fourth-largest drugmaker by market value.7,5

More than £17bn was wiped off AstraZeneca's market value following the reports.7 AstraZeneca and Bristol-Myers Squibb have held early-stage discussions about combining.2 The companies have discussed a potential merger over several months, according to reports.4,3

Bloomberg Intelligence's Sam Fazeli stated a takeover would make no sense.8,5 Investors questioned the rationale for the deal, with some calling it illogical.8,7 Bristol-Myers Squibb shares surged on news of the potential acquisition.6

AstraZeneca's shares fell while Bristol-Myers Squibb's shares rose in trading.6 The reported deal value was initially described as $400bn in multiple outlets.7,6,5,4,3,2 One report cited a potential deal value of $512bn, differing from other estimates.1

The merger talks remain at an early stage and may not result in a deal.2 AstraZeneca is the UK's largest drugmaker by market value.7 AstraZeneca is run from the UK but operates globally.7

媒体意见不一

  • The reported value of the potential deal was described as $400bn in most outlets, while one report cited $512bn.7,6,5,4,3,2,1

为何重要

  • AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, UK.7

  • Bristol-Myers Squibb is a major US-based pharmaceutical company known for cancer treatments and immunology drugs.7,6

  • The pharmaceutical industry has seen a wave of large mergers in recent years as companies seek to expand pipelines and market reach.7,4

本文根据下列 8 篇报道撰写，来自 5 家独立媒体，并逐句核对。它不是其中任何一篇的复制。发现错误？ 告诉我们.

Well corroborated5 outlets
Left1Center4Right0

8 reports from 5 outlets. The numbers in the article point here.

Left-leaning1
Center7

Discussion

0

Comments are screened automatically. Disagreement is fine; abuse and spam are not.

Loading…

Related